about
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX...
Read More
4.97
-0.03
(-0.60%)
38,449
XNAS Volume
High vol. this week
XNAS 05 Sep, 2025 1:09 PM (EDT)
Board Meeting
The next board meeting for enGene Holdings Inc is on 10 Sep 2025 for the purpose of enGene Holdings Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
enGene Holdings Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..